ArticleFrontiers in immunology2024

Dual blockade of IL-17A and IL-36 pathways via a bispecific antibody exhibits enhanced anti-inflammatory potency.

Xiaojuan Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.